This review is based on our recent experience in producing the first commercial recombinant proteins in transgenic plants. We bring forward the issues that have to be considered in the process of selecting and developing a winning transgenic plant production system. From the production point of view
Expression of recombinant human acetylcholinesterase in transgenic tomato plants
β Scribed by Tsafrir S. Mor; Meira Sternfeld; Hermona Soreq; Charles J. Arntzen; Hugh S. Mason
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 328 KB
- Volume
- 75
- Category
- Article
- ISSN
- 0006-3592
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Plant cell culture is an alternative for the production of recombinant human therapeutic proteins because of improved product safety, lower production cost, and capability for eukaryotic postβtranslational modification. In this study, bioreactor production of recombinant human alphaβ1βa
Introduction of human plasma protein genes into the mouse genome to produce transgenic mice furnishes an in vivo model for correlating chromosomal DNA sequences with developmental and tissue-specific expression. The liver produces an array of plasma proteins that circulate throughout the body contri
A number of independently derived transgenic soybean plants expressing a chimeric p-glucuronidase (GUS) gene under the control of the 35s CaMV promoter and a nopaline synthase polyadenylation signal were recovered using direct DNA transfer via electric discharge particle acceleration. Expression of